# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Billings of $115.0 million - $126.0 million, Adjusted EBITDA ($3.0) million - $1.0 million
Cardlytics (NASDAQ:CDLX) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.11) by...
Needham analyst Kyle Peterson maintains Cardlytics (NASDAQ:CDLX) with a Buy and raises the price target from $15 to $17.
The notes will be senior, unsecured obligations of Cardlytics and will accrue interest at a rate of 4.25% per annum, payable se...
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 80 points on Tuesday. The Dow traded up 0...
Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected ...